Hi-C Technology Reveals Actionable Gene Fusions and Rearrangements in Diffuse Large B-Cell Lymphoma Unidentified by Conventional FISH
Genes · 2025
DOI: 10.3390/genes16091093 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, 2025. Verfasst von Sichen Liang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, China. Hauptthemen laut MEDLINE: Lymphoma, Large B-Cell, Diffuse, In Situ Hybridization, Fluorescence, Gene Rearrangement, Gene Fusion. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Johns Hopkins School of Medicine Department of Pathology.
Abstract (Originalsprache)
Background/Objectives: Fluorescence in situ hybridization (FISH) is a standard diagnostic tool for detecting gene fusions and rearrangements in lymphomas but is limited by incomplete genomic coverage, dependence on predefined probes, and difficulty identifying atypical or noncanonical fusion partners. These constraints often result in inconclusive diagnoses in complex lymphoma cases. This study evaluates a novel Hi-C-based sequencing assay from formalin-fixed paraffin-embedded (FFPE) samples to detect clinically significant gene fusions and rearrangements in cases where conventional FISH was inconclusive or expected biomarkers were not detected.
Methods
Five diffuse large B-cell lymphoma cases with previously atypical gene fusions or rearrangements by FISH were analyzed using both standard FISH and a Hi-C-based lymphoma assay. Standard FISH was performed using break-apart probes targeting MYC, BCL2, and BCL6, and dual-fusion probes targeting IGH::MYC and IGH::BCL2. The Hi-C assay utilized high-resolution sequencing of FFPE tissue to map chromatin interactions and identify structural variations across the genome and assessment of their clinical relevance.
Results
In this series of five lymphoma cases, Hi-C detected additional structural variants beyond those identified by FISH. It identified typical and atypical translocation partners of key oncogenes (MYC, BCL2, BCL6), cryptic breakpoints, and novel genomic events, including TP53 loss, KMT2A amplification, and complex rearrangements, which were undetectable by FISH. The Hi-C assay’s whole-genome coverage enabled comprehensive profiling.
Conclusions
The Hi-C-based lymphoma assay offers a transformative diagnostic tool, overcoming FISH limitations by providing unbiased, high-resolution detection of structural variations. This approach enhances diagnostic accuracy and supports personalized therapeutic strategies in lymphoma management, warranting further validation for clinical adoption.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, China.
- Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
- Arima Genomics, Carlsbad, CA 92011, USA.
ORCID-Profile: Sichen Liang, Victoria Stinnett, Jen Ghabrial, Alex R Hastie, Ying S Zou
Förderung
- Johns Hopkins School of Medicine Department of Pathology
Zitieren
APA
Liang, S., Ament, C., Klausner, M., Stinnett, V., Morsberger, L., Ghabrial, J., Middlezong, W., Schmitt, A. D., Hastie, A. R., & Zou, Y. S. (2025). Hi-C Technology Reveals Actionable Gene Fusions and Rearrangements in Diffuse Large B-Cell Lymphoma Unidentified by Conventional FISH. Genes. https://doi.org/10.3390/genes16091093
Vancouver
Liang S, Ament C, Klausner M, Stinnett V, Morsberger L, Ghabrial J, et al. Hi-C Technology Reveals Actionable Gene Fusions and Rearrangements in Diffuse Large B-Cell Lymphoma Unidentified by Conventional FISH. Genes. 2025. doi:10.3390/genes16091093
BibTeX
@article{Liang2025,
author = {Liang, Sichen and Ament, Candice and Klausner, Melanie and Stinnett, Victoria and Morsberger, Laura and Ghabrial, Jen and Middlezong, William and Schmitt, Anthony D and Hastie, Alex R and Zou, Ying S},
title = {Hi-C Technology Reveals Actionable Gene Fusions and Rearrangements in Diffuse Large B-Cell Lymphoma Unidentified by Conventional FISH},
journal = {Genes},
year = {2025},
doi = {10.3390/genes16091093}
}
EUVIMED